Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
- PMID: 37332964
- PMCID: PMC10276217
- DOI: 10.1016/j.heliyon.2023.e16977
Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
Abstract
Systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (SSc) are the most common rheumatic autoimmune diseases/disorders (RADs) that affect autologous connective tissues as a result of the breakdown of the self-tolerance mechanisms of the immune system. Prolactin, a glycoprotein hormone, has been known for its crucial role in the pathogenesis of these rheumatic autoimmune diseases. In addition to regulating lymphocyte proliferation and antibody synthesis, prolactin is also responsible for regulating cytokine production. Moreover, it contributes to the breakdown of central and peripheral tolerance mechanisms of B lymphocytes. Given the crucial role of prolactin in the pathogenesis of the mentioned RADs, prolactin may contribute to their pathogenesis by the breakdown of tolerance. In the present study, the key role of prolactin to the breakdown of B lymphocyte tolerance and its possible implication for the pathogenesis of these diseases is discussed. Current literature supports prolactin's role in the breakdown of B lymphocyte central and peripheral tolerance mechanisms, such apoptosis, receptor editing, and also anergy. Therefore, prolactin may contribute to the pathogenesis of RADs by the breakdown of B lymphocyte tolerance. However, more investigations, particularly in RA and SSc animal models, are required to precisely address the pathologic role of prolactin.
Keywords: Autoimmune disease; B lymphocyte; B lymphocyte tolerance; Prolactin; Rheumatic autoimmune disease; Tolerance.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Clapp C., et al. Regulation of blood vessels by prolactin and vasoinhibins. Adv. Exp. Med. Biol. 2015;846:83–95. - PubMed
-
- Bewley T.A., Li C.H. Circular dichroism studies on human pituitary growth hormone and ovine pituitary lactogenic hormone. Biochemistry. 1972;11(5):884–888. - PubMed
-
- Goffin V., Martial J.A., Summers N.L. Use of a model to understand prolactin and growth hormone specificities. Protein Eng. Des. Sel. 1995;8(12):1215–1231. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
